Stratrix
On the Record · Varian Medical Systems

Varian Medical Systems acquisitions, on the record

The businesses Varian Medical Systems bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

BusinessDealWhenValue
Mobius Medical Systems
Word for word“We purchased Mobius Medical Systems ("Mobius") in February 2018.” 10-K for 2018
acquisitionFebruary 2018—
humediQ GmbH
Word for word“In July 2018, we acquired humediQ GmbH, which markets and sells the IDENTIFY ™ products that enable patient and accessory verification, patient setup position, and motion monitoring for radiation oncology treatments.” 10-K for 2018
acquisitionJuly 2018—
Sirtex Medical Limited
Word for word“On January 30, 2018, we signed an agreement to acquire Sirtex Medical Limited ("Sirtex"), an Australian company that was listed on the Australian Securities Exchange, for A$28 per share or approximately A$1.6 billion.” 10-K for 2018
agreed acquisitionOn January 30, 2018for A$28 per share or approximately A$1.6 billion
four companies, including two privately-held software companies, a distributor of radiotherapy equipment, and a manufacturer of a surface-guided radiation therapy positioning and motion management system
Word for word“In fiscal year 2018, we acquired four companies, including two privately-held software companies, a distributor of radiotherapy equipment, and a manufacturer of a surface-guided radiation therapy positioning and motion management system, for an aggregate purchase price of $109.0 million .” 10-K for 2018
acquisitionIn fiscal year 2018$109.0 million
Cancer Treatment Services International ("CTSI")
Word for word“We acquired CTSI for a purchase price of $277.0 million , consisting of $262.8 million of cash consideration, $8.2 million of contingent consideration, and $6.0 million of other consideration.” 10-K for 2019
acquisition—$277.0 million
Endocare, Inc ("Endocare") and Alicon Pharmaceutical Technology Company. Ltd ("Alicon")
Word for word“We acquired Endocare and Alicon for a combined purchase price of $210.0 million consisting of $197.4 million of cash consideration and $12.6 million of contingent consideration.” 10-K for 2019
acquisition—$210.0 million
Boston Scientific's embolics microspheres business
Word for word“We acquired the business for a purchase price of $ 90.0 million in cash consideration.” 10-K for 2019
acquisition——
Augmenix
Word for word“In fiscal year 2019, earnings from continuing operations before taxes includes a $22.0 million gain on the sale of our investment in Augmenix, a $50.5 million goodwill impairment charge related to our Proton Solutions business, a $20.8 million charge associated with the write-off of in-process research and development expenses related to an acquisition, and an $18.6 million charge to acquisition-related expenses due to an increase to the fair value of contingent consideration related to an acquisition.” 10-K for 2019
divestitureIn fiscal year 2019$22.0 million gain
As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year endedCash paid for acquisitions (net of cash acquired)Goodwill from acquisitions
2016-09-30$21.1 million$11.4 million
2017-09-29$3 million—
2018-09-28$109 million$72.1 million
2019-09-27$576.2 million$372.3 million
2020-10-02$36.2 million$15.7 million

Deal filings since 2016

Read from Varian Medical Systems’s annual reports (10-K for 2020, 10-K for 2019, 10-K for 2018) and the financial data it files with the SEC, as of 2020-11-25. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.